div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imageimg data-url=european-medicines-agency-response-of-22-may-2014-to-ms-emily-oreilly-europeanhtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: European Medicines Agency response of 22 May 2014 to · Ms Emily OReilly European Ombudsman 1 avenue du President Robert Schuman CS30403 F-67001 Strasbourg Cedex France 22 May loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader034vdocumentssitereader034viewer20220428085f8b959396ae2c34ac447f9ahtml5thumbnails1jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imageimg data-url=european-medicines-agency-response-of-22-may-2014-to-ms-emily-oreilly-europeanhtmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: European Medicines Agency response of 22 May 2014 to · Ms Emily OReilly European Ombudsman 1 avenue du President Robert Schuman CS30403 F-67001 Strasbourg Cedex France 22 May loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader034vdocumentssitereader034viewer20220428085f8b959396ae2c34ac447f9ahtml5thumbnails2jpg width=140 height=200 divdiv